Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinib.

Burger JA, Li KW, Keating MJ, Sivina M, Amer AM, Garg N, Ferrajoli A, Huang X, Kantarjian H, Wierda WG, O'Brien S, Hellerstein MK, Turner SM, Emson CL, Chen SS, Yan XJ, Wodarz D, Chiorazzi N.

JCI Insight. 2017 Jan 26;2(2):e89904. doi: 10.1172/jci.insight.89904.

2.

Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood.

Decaris ML, Li KW, Emson CL, Gatmaitan M, Liu S, Wang Y, Nyangau E, Colangelo M, Angel TE, Beysen C, Cui J, Hernandez C, Lazaro L, Brenner DA, Turner SM, Hellerstein MK, Loomba R.

Hepatology. 2017 Jan;65(1):78-88. doi: 10.1002/hep.28860. Epub 2016 Nov 15.

3.

Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease.

Decaris ML, Emson CL, Li K, Gatmaitan M, Luo F, Cattin J, Nakamura C, Holmes WE, Angel TE, Peters MG, Turner SM, Hellerstein MK.

PLoS One. 2015 Apr 24;10(4):e0123311. doi: 10.1371/journal.pone.0123311. eCollection 2015.

4.

Proteomic analysis of altered extracellular matrix turnover in bleomycin-induced pulmonary fibrosis.

Decaris ML, Gatmaitan M, FlorCruz S, Luo F, Li K, Holmes WE, Hellerstein MK, Turner SM, Emson CL.

Mol Cell Proteomics. 2014 Jul;13(7):1741-52. doi: 10.1074/mcp.M113.037267. Epub 2014 Apr 16.

5.

Extracellular matrix proteins: a positive feedback loop in lung fibrosis?

Blaauboer ME, Boeijen FR, Emson CL, Turner SM, Zandieh-Doulabi B, Hanemaaijer R, Smit TH, Stoop R, Everts V.

Matrix Biol. 2014 Feb;34:170-8. doi: 10.1016/j.matbio.2013.11.002. Epub 2013 Nov 27.

6.

A pilot study demonstrating a non-invasive method for the measurement of protein turnover in skin disorders: application to psoriasis.

Emson CL, Fitzmaurice S, Lindwall G, Li KW, Hellerstein MK, Maibach HI, Liao W, Turner SM.

Clin Transl Med. 2013 Jun 17;2:12. doi: 10.1186/2001-1326-2-12. eCollection 2013.

7.

Novel combination of collagen dynamics analysis and transcriptional profiling reveals fibrosis-relevant genes and pathways.

Blaauboer ME, Emson CL, Verschuren L, van Erk M, Turner SM, Everts V, Hanemaaijer R, Stoop R.

Matrix Biol. 2013 Oct-Nov;32(7-8):424-31. doi: 10.1016/j.matbio.2013.04.005. Epub 2013 May 3.

PMID:
23648810
8.

Mannose receptor 2 attenuates renal fibrosis.

López-Guisa JM, Cai X, Collins SJ, Yamaguchi I, Okamura DM, Bugge TH, Isacke CM, Emson CL, Turner SM, Shankland SJ, Eddy AA.

J Am Soc Nephrol. 2012 Feb;23(2):236-51. doi: 10.1681/ASN.2011030310. Epub 2011 Nov 17.

9.

Deuterium and neutrophil kinetics.

Li KW, Turner SM, Emson CL, Hellerstein MK, Dale DC.

Blood. 2011 Jun 2;117(22):6052-3; author reply 6053-4. doi: 10.1182/blood-2010-12-322271. No abstract available.

PMID:
21636721
10.

Differential in vivo effects on target pathways of a novel arylpyrazole glucocorticoid receptor modulator compared with prednisolone.

Roohk DJ, Varady KA, Turner SM, Emson CL, Gelling RW, Shankaran M, Lindwall G, Shipp LE, Scanlan TS, Wang JC, Hellerstein MK.

J Pharmacol Exp Ther. 2010 Apr;333(1):281-9. doi: 10.1124/jpet.109.162487. Epub 2010 Jan 11.

PMID:
20065017
11.

Mfge8 diminishes the severity of tissue fibrosis in mice by binding and targeting collagen for uptake by macrophages.

Atabai K, Jame S, Azhar N, Kuo A, Lam M, McKleroy W, Dehart G, Rahman S, Xia DD, Melton AC, Wolters P, Emson CL, Turner SM, Werb Z, Sheppard D.

J Clin Invest. 2009 Dec;119(12):3713-22. doi: 10.1172/JCI40053. Epub 2009 Nov 2.

12.

IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13.

Fallon PG, Jolin HE, Smith P, Emson CL, Townsend MJ, Fallon R, Smith P, McKenzie AN.

Immunity. 2002 Jul;17(1):7-17.

13.

IL-13 overexpression predisposes to anaphylaxis following antigen sensitization.

Fallon PG, Emson CL, Smith P, McKenzie AN.

J Immunol. 2001 Feb 15;166(4):2712-6.

14.

IL-13 is a susceptibility factor for Leishmania major infection.

Matthews DJ, Emson CL, McKenzie GJ, Jolin HE, Blackwell JM, McKenzie AN.

J Immunol. 2000 Feb 1;164(3):1458-62.

15.

Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses.

McKenzie GJ, Fallon PG, Emson CL, Grencis RK, McKenzie AN.

J Exp Med. 1999 May 17;189(10):1565-72.

16.

Impaired development of Th2 cells in IL-13-deficient mice.

McKenzie GJ, Emson CL, Bell SE, Anderson S, Fallon P, Zurawski G, Murray R, Grencis R, McKenzie AN.

Immunity. 1998 Sep;9(3):423-32.

17.

Supplemental Content

Loading ...
Support Center